(KREF) KKR Real Estate Finance - Overview
Exchange: NYSE •
Country: United States •
Currency: USD •
Type: Common Stock •
ISIN: US48251K1007
Stock: Loans, Credit, CRE, Senior, Debt
Total Rating 31
Risk 62
Buy Signal -1.74
EPS (Earnings per Share)
Revenue
Dividends
| Dividend Yield | 10.98% |
| Yield on Cost 5y | 9.48% |
| Yield CAGR 5y | -15.76% |
| Payout Consistency | 92.7% |
| Payout Ratio | 5.6% |
| Risk 5d forecast | |
|---|---|
| Volatility | 49.1% |
| Relative Tail Risk | -2.66% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -1.15 |
| Alpha | -40.60 |
| Character TTM | |
|---|---|
| Beta | 0.784 |
| Beta Downside | 0.962 |
| Drawdowns 3y | |
|---|---|
| Max DD | 34.30% |
| CAGR/Max DD | -0.34 |
Description: KREF KKR Real Estate Finance December 27, 2025
KRR Real Estate Finance Trust Inc. (KREF) is a U.S. mortgage REIT that originates and purchases senior transitional loans secured by commercial real-estate assets. It invests in both leveraged and unleveraged CRE loans, and, by electing REIT tax status, it avoids federal corporate income tax provided it distributes at least 90 % of taxable earnings to shareholders. The company was incorporated in 2014 and is based in New York.
As of the most recent filing, KREF’s loan portfolio stood at roughly $8.2 billion with a weighted-average loan term of 3.2 years, and the trust reported a net interest margin of about 2.1 %. The dividend yield hovered near 5.2 % and its leverage ratio was approximately 1.2×, reflecting moderate use of debt. Key macro drivers include the Fed’s policy rate (which influences loan yields and refinancing risk) and the health of the U.S. commercial-real-estate market, particularly office and industrial vacancy trends that affect loan performance.
For a deeper quantitative comparison of KREF’s risk-adjusted returns, you might explore the ValueRay platform.
Piotroski VR‑10 (Strict, 0-10) 4.0
| Net Income: -6.63m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.01 > 0.02 and ΔFCF/TA -1.00 > 1.0 |
| NWC/Revenue: 51.18% < 20% (prev 1722 %; Δ -1671 % < -1%) |
| CFO/TA 0.01 > 3% & CFO 73.9m > Net Income -6.63m |
| Net Debt (-204.1m) to EBITDA (157.9m): -1.29 < 3 |
| Current Ratio: 1.87 > 1.5 & < 3 |
| Outstanding Shares: last quarter (65.9m) vs 12m ago -5.12% < -2% |
| Gross Margin: 90.49% > 18% (prev 0.91%; Δ 8958 % > 0.5%) |
| Asset Turnover: 3.15% > 50% (prev 5.20%; Δ -2.05% > 0%) |
| Interest Coverage Ratio: 0.44 > 6 (EBITDA TTM 157.9m / Interest Expense TTM 335.9m) |
Altman Z'' -0.06
| A: 0.02 (Total Current Assets 229.8m - Total Current Liabilities 123.0m) / Total Assets 6.48b |
| B: -0.07 (Retained Earnings -458.0m / Total Assets 6.48b) |
| C: 0.02 (EBIT TTM 147.6m / Avg Total Assets 6.63b) |
| D: -0.09 (Book Value of Equity -457.4m / Total Liabilities 5.20b) |
| Altman-Z'' Score: -0.06 = B |
What is the price of KREF shares?
As of February 09, 2026, the stock is trading at USD 7.32 with a total of 1,150,309 shares traded.
Over the past week, the price has changed by -11.91%, over one month by -6.99%, over three months by -5.95% and over the past year by -25.46%.
Over the past week, the price has changed by -11.91%, over one month by -6.99%, over three months by -5.95% and over the past year by -25.46%.
Is KREF a buy, sell or hold?
KKR Real Estate Finance has received a consensus analysts rating of 4.20.
Therefore, it is recommended to buy KREF.
- StrongBuy: 2
- Buy: 2
- Hold: 1
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the KREF price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 10.2 | 38.7% |
| Analysts Target Price | 10.2 | 38.7% |
| ValueRay Target Price | 7.4 | 1.4% |
KREF Fundamental Data Overview February 03, 2026
P/E Forward = 11.6686
P/S = 8.7692
P/B = 0.4495
P/EG = 5.13
Revenue TTM = 208.7m USD
EBIT TTM = 147.6m USD
EBITDA TTM = 157.9m USD
Long Term Debt = 3.57b USD (from longTermDebt, last quarter)
Short Term Debt = 80.0m USD (from shortTermDebt, last fiscal year)
Debt = 3.86b USD (from shortLongTermDebtTotal, last fiscal year)
Net Debt = -204.1m USD (from netDebt column, last quarter)
Enterprise Value = 4.20b USD (543.8m + Debt 3.86b - CCE 204.1m)
Interest Coverage Ratio = 0.44 (Ebit TTM 147.6m / Interest Expense TTM 335.9m)
EV/FCF = 58.18x (Enterprise Value 4.20b / FCF TTM 72.3m)
FCF Yield = 1.72% (FCF TTM 72.3m / Enterprise Value 4.20b)
FCF Margin = 34.62% (FCF TTM 72.3m / Revenue TTM 208.7m)
Net Margin = -3.17% (Net Income TTM -6.63m / Revenue TTM 208.7m)
Gross Margin = 90.49% ((Revenue TTM 208.7m - Cost of Revenue TTM 19.8m) / Revenue TTM)
Gross Margin QoQ = none% (prev 89.54%)
Tobins Q-Ratio = 0.65 (Enterprise Value 4.20b / Total Assets 6.48b)
Interest Expense / Debt = 2.14% (Interest Expense 82.7m / Debt 3.86b)
Taxrate = 36.74% (4.69m / 12.8m)
NOPAT = 93.3m (EBIT 147.6m * (1 - 36.74%))
Current Ratio = 1.87 (Total Current Assets 229.8m / Total Current Liabilities 123.0m)
Debt / Equity = 3.14 (Debt 3.86b / totalStockholderEquity, last quarter 1.23b)
Debt / EBITDA = -1.29 (Net Debt -204.1m / EBITDA 157.9m)
Debt / FCF = -2.82 (Net Debt -204.1m / FCF TTM 72.3m)
Total Stockholder Equity = 1.28b (last 4 quarters mean from totalStockholderEquity)
RoA = -0.10% (Net Income -6.63m / Total Assets 6.48b)
RoE = -0.52% (Net Income TTM -6.63m / Total Stockholder Equity 1.28b)
RoCE = 3.04% (EBIT 147.6m / Capital Employed (Equity 1.28b + L.T.Debt 3.57b))
RoIC = 1.79% (NOPAT 93.3m / Invested Capital 5.22b)
WACC = 2.27% (E(543.8m)/V(4.41b) * Re(8.80%) + D(3.86b)/V(4.41b) * Rd(2.14%) * (1-Tc(0.37)))
Discount Rate = 8.80% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -33.33 | Cagr: -2.56%
[DCF Debug] Terminal Value 85.99% ; FCFF base≈100.6m ; Y1≈97.2m ; Y5≈96.1m
Fair Price DCF = 47.08 (EV 2.88b - Net Debt -204.1m = Equity 3.08b / Shares 65.5m; r=5.90% [WACC]; 5y FCF grow -4.55% → 2.90% )
EPS Correlation: -38.86 | EPS CAGR: -6.61% | SUE: -0.76 | # QB: 0
Revenue Correlation: -1.62 | Revenue CAGR: -12.98% | SUE: -0.08 | # QB: 0
EPS next Quarter (2026-03-31): EPS=0.19 | Chg30d=+0.017 | Revisions Net=-1 | Analysts=5
EPS next Year (2026-12-31): EPS=0.65 | Chg30d=-0.001 | Revisions Net=-1 | Growth EPS=+115.9% | Growth Revenue=-6.6%
P/S = 8.7692
P/B = 0.4495
P/EG = 5.13
Revenue TTM = 208.7m USD
EBIT TTM = 147.6m USD
EBITDA TTM = 157.9m USD
Long Term Debt = 3.57b USD (from longTermDebt, last quarter)
Short Term Debt = 80.0m USD (from shortTermDebt, last fiscal year)
Debt = 3.86b USD (from shortLongTermDebtTotal, last fiscal year)
Net Debt = -204.1m USD (from netDebt column, last quarter)
Enterprise Value = 4.20b USD (543.8m + Debt 3.86b - CCE 204.1m)
Interest Coverage Ratio = 0.44 (Ebit TTM 147.6m / Interest Expense TTM 335.9m)
EV/FCF = 58.18x (Enterprise Value 4.20b / FCF TTM 72.3m)
FCF Yield = 1.72% (FCF TTM 72.3m / Enterprise Value 4.20b)
FCF Margin = 34.62% (FCF TTM 72.3m / Revenue TTM 208.7m)
Net Margin = -3.17% (Net Income TTM -6.63m / Revenue TTM 208.7m)
Gross Margin = 90.49% ((Revenue TTM 208.7m - Cost of Revenue TTM 19.8m) / Revenue TTM)
Gross Margin QoQ = none% (prev 89.54%)
Tobins Q-Ratio = 0.65 (Enterprise Value 4.20b / Total Assets 6.48b)
Interest Expense / Debt = 2.14% (Interest Expense 82.7m / Debt 3.86b)
Taxrate = 36.74% (4.69m / 12.8m)
NOPAT = 93.3m (EBIT 147.6m * (1 - 36.74%))
Current Ratio = 1.87 (Total Current Assets 229.8m / Total Current Liabilities 123.0m)
Debt / Equity = 3.14 (Debt 3.86b / totalStockholderEquity, last quarter 1.23b)
Debt / EBITDA = -1.29 (Net Debt -204.1m / EBITDA 157.9m)
Debt / FCF = -2.82 (Net Debt -204.1m / FCF TTM 72.3m)
Total Stockholder Equity = 1.28b (last 4 quarters mean from totalStockholderEquity)
RoA = -0.10% (Net Income -6.63m / Total Assets 6.48b)
RoE = -0.52% (Net Income TTM -6.63m / Total Stockholder Equity 1.28b)
RoCE = 3.04% (EBIT 147.6m / Capital Employed (Equity 1.28b + L.T.Debt 3.57b))
RoIC = 1.79% (NOPAT 93.3m / Invested Capital 5.22b)
WACC = 2.27% (E(543.8m)/V(4.41b) * Re(8.80%) + D(3.86b)/V(4.41b) * Rd(2.14%) * (1-Tc(0.37)))
Discount Rate = 8.80% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -33.33 | Cagr: -2.56%
[DCF Debug] Terminal Value 85.99% ; FCFF base≈100.6m ; Y1≈97.2m ; Y5≈96.1m
Fair Price DCF = 47.08 (EV 2.88b - Net Debt -204.1m = Equity 3.08b / Shares 65.5m; r=5.90% [WACC]; 5y FCF grow -4.55% → 2.90% )
EPS Correlation: -38.86 | EPS CAGR: -6.61% | SUE: -0.76 | # QB: 0
Revenue Correlation: -1.62 | Revenue CAGR: -12.98% | SUE: -0.08 | # QB: 0
EPS next Quarter (2026-03-31): EPS=0.19 | Chg30d=+0.017 | Revisions Net=-1 | Analysts=5
EPS next Year (2026-12-31): EPS=0.65 | Chg30d=-0.001 | Revisions Net=-1 | Growth EPS=+115.9% | Growth Revenue=-6.6%